Work

Supplementary Figures 1 through 4 from Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers

Year: 2023

Type: supplementary-materials

Abstract: Contains supplemental figures 1 through 4 and their corresponding legends. Suppl Fig 1 demonstrates summary growth curves for in vivo MOC1 and MOC2 experiments. Suppl Fig 2 is validation of p15E antigen expression in MOC cell lines. Supple Fig 3 demonstrates immune correlative data for treated MOC2-tumor nearing mice. Finally, Suppl Fig 4 is validation of our tumor and spleen cellular depletion with our described methods.

DOI: 10.1158/2326-6066.22537361

Authors: Ellen C. Moore, Harrison A. Cash, Andria M. Caruso, Ravindra Uppaluri, James W. Hodge, Carter Van Waes, Clint T. Allen

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362552007

Cites:

Cited by:

Related to: 10